Laura McVeigh
@drlauramcveigh
Research Fellow @EdinUni_IGC | Glioblastoma | Nanomedicine 👩🏼🔬🔬🧠
ID: 1126456521221496832
09-05-2019 11:58:57
76 Tweet
353 Takipçi
999 Takip Edilen
Using targeted microbubbles to administer toxic cancer drugs bit.ly/2VPnxqS via @universityleeds EurekAlert!
What fantastic recognition for 10 years hard work for our fantastic multidisciplinary team! Well done everyone! And fingers crossed....Leeds Microbubbles Open Research Leeds
What a proud moment. A decade of dedicated research in developing Therapeutic Microbubbles in the treatment of cancer has now been shortlisted for Bionow Project of the Year! Well done to our highly talented team! University of Leeds Medicines Discovery Catapult
Prof Neil Carragher is leading a collaborative multi-disciplinary research programme of international experts to find new drug targets and new drug combinations to treat glioblastomas. Read more about this work, funded by The Brain Tumour Charity : thebraintumourcharity.org/brain-tumour-d… #RareDiseaseDay
“Targeting FAK in anticancer combination therapies” – review by John Dawson et al. published in Nature Reviews Cancer. Good read for all interested in Focal Adhesion Kinase and anticancer therapeutics: nature.com/articles/s4156… Edinburgh Cancer Research @EdinUni_MeetCIR UCSD Health Moores Cancer Center CRCERA
Latest #microbubble work from Coletta lab & Leeds Microbubbles. Using microbubbles to deliver an 'undeliverable' hydrophobic drug to an in vivo model of CRC. Victoria Sally A. Peyman @mclaughlanlab steve evans Check it out 👇🏻 doi.org/10.1016/j.nano…
Optimal Drug Delivery to Tumours Using Ultrasound-Triggered Therapeutic #Microbubbles. Check out the latest work from Leeds Microbubbles and the final paper from my PhD! 🥳 mdpi.com/1538762 #mdpipharmaceutics via Pharmaceutics MDPI
Excited to share our latest review in Frontiers - Oncology #Glioblastoma and the search for non-hypothesis driven combination therapeutics in academia Edinburgh Cancer Research @LabEbner Margaret Frame Joelle Straehla frontiersin.org/articles/10.33…